ENvue Medical (FEED) Return on Sales (2014 - 2026)

ENvue Medical (FEED) has 13 years of Return on Sales data on file, last reported at 0.06% in Q1 2026.

• On a quarterly basis, Return on Sales fell 4.0% year-over-year to 0.06% in Q1 2026; TTM through Mar 2026 was 0.09%, a 9.0% decrease from a year earlier, with the FY2025 full-year figure at 0.07%, down 7.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.06%, up from 0.41% in the prior quarter.
• Over the last five years, Return on Sales for FEED reached as high as 0.2% in Q4 2022 and fell as low as 0.41% in Q4 2025.
• Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.03% in 2024.
• Across the five-year window, Return on Sales jumped 44 bps in 2022 and sank 46 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.2% in 2022, then tumbled by 103 bps to 0.01% in 2023, then jumped by 806 bps to 0.05% in 2024, then plunged by 944 bps to 0.41% in 2025, then soared by 86 bps to 0.06% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.06% in Q1 2026, 0.41% in Q4 2025, and 0.01% in Q3 2025.